| Financial Year |
March 31 2023 |
| Monetary Funds |
223,126,050.68 |
| Held-for-trading Financial Assets |
8,501,615.80 |
| Notes Receivable |
30,964,006.67 |
| Accounts Receivable |
173,753,786.04 |
| Advances to Suppliers |
25,901,610.60 |
| Other Receivables |
65,543,809.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
127,753,108.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
7,591,480.00 |
| Other Current Assets |
2,615,600.38 |
| Total Current Assets |
670,041,533.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
200,000.00 |
| Long-term Equity Investment |
73,542,700.48 |
| Investment Properties |
20,941,208.91 |
| Fixed Assetes |
247,426,059.38 |
| Under-construction Projects |
711,040,854.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
111,473,962.82 |
| R&D expenses |
628,889.51 |
| Goodwill |
15,114,529.45 |
| Long-Term Deferred and Prepaid Expenses |
1,693,861.12 |
| Deferred Income Tax Assets |
13,489,701.12 |
| Other Non-Current Assets |
6,237,509.68 |
| Sub-Total of Non-Current Assets |
1,248,473,741.10 |
| Total Assets |
1,918,515,274.53 |
| Short-Term Loans |
134,016,408.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
147,000,618.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,166,760.67 |
| Taxes Payable |
6,771,229.26 |
| Interest Payable |
-- |
| Dividend Payable |
2,400,000.00 |
| Other payables |
21,011,333.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
50,374,839.82 |
| Other Current Liabilities |
12,149,926.98 |
| Sub-Total of Current Liabilities |
386,045,732.68 |
| Long-term Loans |
451,589,311.50 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
200,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,586,537.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
498,243,492.48 |
| Total Liabilities |
884,289,225.16 |
| Paid-In Capital(Or Share Stock) |
99,880,000.00 |
| Capital Surplus |
412,016,831.13 |
| Surplus Reserve |
56,212,692.97 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
401,971,231.00 |
| Minority Stockholder's Interest |
52,293,034.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
981,933,014.49 |
| Owner's Equity（Stockholder's Equity） |
1,034,226,049.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,918,515,274.53 |
